These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events. Kabir S. Helicobacter; 2009 Jun; 14(3):159-71. PubMed ID: 19702845 [Abstract] [Full Text] [Related]
3. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Maehata Y, Nakamura S, Fujisawa K, Esaki M, Moriyama T, Asano K, Fuyuno Y, Yamaguchi K, Egashira I, Kim H, Kanda M, Hirahashi M, Matsumoto T. Gastrointest Endosc; 2012 Jan; 75(1):39-46. PubMed ID: 22018552 [Abstract] [Full Text] [Related]
9. The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer. Ogura K, Hirata Y, Yanai A, Shibata W, Ohmae T, Mitsuno Y, Maeda S, Watabe H, Yamaji Y, Okamoto M, Yoshida H, Kawabe T, Omata M. J Clin Gastroenterol; 2008 Mar; 42(3):279-83. PubMed ID: 18223496 [Abstract] [Full Text] [Related]
12. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M, Japan Gast Study Group. Lancet; 2008 Aug 02; 372(9636):392-7. PubMed ID: 18675689 [Abstract] [Full Text] [Related]
13. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Kamada T, Hata J, Sugiu K, Kusunoki H, Ito M, Tanaka S, Inoue K, Kawamura Y, Chayama K, Haruma K. Aliment Pharmacol Ther; 2005 May 01; 21(9):1121-6. PubMed ID: 15854174 [Abstract] [Full Text] [Related]
14. Prevention of gastric cancer: a challenging but feasible task. Fry LC, Mönkemüller K, Malfertheiner P. Acta Gastroenterol Latinoam; 2007 Jun 01; 37(2):110-7. PubMed ID: 17684942 [Abstract] [Full Text] [Related]
17. Role of metallothionein in Helicobacter pylori-positive gastric mucosa with or without early gastric cancer and the effect on its expression after eradication therapy. Mitani T, Shirasaka D, Aoyama N, Miki I, Morita Y, Ikehara N, Matsumoto Y, Okuno T, Toyoda M, Miyachi H, Yoshida S, Chayahara N, Hori J, Tamura T, Azuma T, Kasuga M. J Gastroenterol Hepatol; 2008 Aug 01; 23(8 Pt 2):e334-9. PubMed ID: 17725597 [Abstract] [Full Text] [Related]
18. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? de Vries AC, Kuipers EJ, Rauws EA. Am J Gastroenterol; 2009 Jun 01; 104(6):1342-5. PubMed ID: 19491846 [Abstract] [Full Text] [Related]
19. [Helicobacter pylori eradication therapy does not prevent gastric cancer development in all patients]. Take S, Ishiki K, Mizuno M. Gan To Kagaku Ryoho; 2011 Mar 01; 38(3):353-7. PubMed ID: 21403436 [Abstract] [Full Text] [Related]
20. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT. Gastroenterology; 2009 Nov 01; 137(5):1641-8.e1-2. PubMed ID: 19664631 [Abstract] [Full Text] [Related] Page: [Next] [New Search]